ICON PLC (ICLR) - Total Assets

Latest as of September 2025: $16.51 Billion USD

Based on the latest financial reports, ICON PLC (ICLR) holds total assets worth $16.51 Billion USD as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore ICON PLC long-term investment allocation to see how much of total assets are deployed in long-term investments.

ICON PLC - Total Assets Trend (1998–2024)

This chart illustrates how ICON PLC's total assets have evolved over time, based on quarterly financial data. Check ICON PLC liquidity resilience to evaluate the company's liquid asset resilience ratio.

ICON PLC - Asset Composition Analysis

Current Asset Composition (December 2024)

ICON PLC's total assets of $16.51 Billion consist of 20.9% current assets and 79.1% non-current assets.

Asset Category Amount (USD) % of Total Assets
Cash & Equivalents $0.00 3.2%
Accounts Receivable $2.85 Billion 16.9%
Inventory $0.00 0.0%
Property, Plant & Equipment $0.00 0.0%
Intangible Assets $3.56 Billion 21.1%
Goodwill $9.05 Billion 53.6%

Asset Composition Trend (1998–2024)

This chart illustrates how ICON PLC's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see market value of ICON PLC.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: ICON PLC's current assets represent 20.9% of total assets in 2024, a decrease from 83.4% in 1998.
  • Cash Position: Cash and equivalents constituted 3.2% of total assets in 2024, down from 12.8% in 1998.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 74.0% of total assets, an increase from 0.0% in 1998.
  • Asset Diversification: The largest asset category is goodwill at 53.6% of total assets.

ICON PLC Competitors by Total Assets

Key competitors of ICON PLC based on total assets are shown below.

Company Country Total Assets
Guangzhou Kingmed Diagnostics Group Co Ltd
SHG:603882
China CN¥9.20 Billion
SMO ClinPlus Co. Ltd.
SHE:301257
China CN¥1.52 Billion
Healius Ltd
AU:HLS
Australia AU$1.77 Billion
RHYTHM Biosciences Ltd
AU:RHY
Australia AU$3.10 Million
Check-Cap Ltd.
NASDAQ:MBAI
USA $7.49 Million
Sonic Healthcare Ltd
AU:SHL
Australia AU$17.03 Billion
Integral Diagnostics Ltd
AU:IDX
Australia AU$1.43 Billion
Australian Clinical Labs Ltd
AU:ACL
Australia AU$562.50 Million

ICON PLC - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 1.06 1.34 1.87
Quick Ratio 1.06 1.34 1.87
Cash Ratio 0.00 0.00 0.00
Working Capital $189.43 Million $960.10 Million $979.03 Million

ICON PLC - Advanced Valuation Insights

This section examines the relationship between ICON PLC's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 1.02
Latest Market Cap to Assets Ratio 0.54
Asset Growth Rate (YoY) -0.7%
Total Assets $16.88 Billion
Market Capitalization $9.04 Billion USD

Valuation Analysis

Below Book Valuation: The market values ICON PLC's assets below their book value (0.54x), which may indicate investor concerns about asset quality or future growth.

Slight Asset Contraction: ICON PLC's assets decreased by 0.7% over the past year, which may reflect streamlining or optimization of resources.

Annual Total Assets for ICON PLC (1998–2024)

The table below shows the annual total assets of ICON PLC from 1998 to 2024.

Year Total Assets Change
2024-12-31 $16.88 Billion -0.66%
2023-12-31 $16.99 Billion -1.14%
2022-12-31 $17.19 Billion -1.16%
2021-12-31 $17.39 Billion +406.09%
2020-12-31 $3.44 Billion +18.16%
2019-12-31 $2.91 Billion +21.84%
2018-12-31 $2.39 Billion +9.17%
2017-12-31 $2.19 Billion +19.72%
2016-12-31 $1.83 Billion +6.22%
2015-12-31 $1.72 Billion +12.51%
2014-12-31 $1.53 Billion +5.92%
2013-12-31 $1.44 Billion +19.99%
2012-12-31 $1.20 Billion +16.09%
2011-12-31 $1.04 Billion +9.05%
2010-12-31 $949.54 Million +4.53%
2009-12-31 $908.40 Million +4.74%
2008-12-31 $867.28 Million +25.12%
2007-12-31 $693.14 Million +45.51%
2006-12-31 $476.34 Million +36.46%
2005-12-31 $349.07 Million +4.10%
2004-12-31 $335.32 Million +79.39%
2003-12-31 $186.92 Million -20.46%
2002-12-31 $235.01 Million +58.45%
2001-12-31 $148.32 Million +33.78%
2000-12-31 $110.87 Million +10.74%
1999-12-31 $100.12 Million +6.74%
1998-12-31 $93.80 Million --

About ICON PLC

NASDAQ:ICLR USA Diagnostics & Research
Market Cap
$9.04 Billion
Market Cap Rank
#2445 Global
#875 in USA
Share Price
$118.45
Change (1 day)
+4.04%
52-Week Range
$80.08 - $202.92
All Time High
$346.20
About

ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical stu… Read more